China Oral Industry Group Holdings Limited

China Oral Industry Group Holdings Limited

HHKEX:8406
0.07
HKD
+0.00
(+3.03%)
50.17MMarket Cap
China Oral Industry Group Holdings Limited
HKEX:8406
(Hong Kong Exchange)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.25
0.26
0.24
0.28
0.33
0.37
0.26
0.17
0.21
0.12
- -
Revenue per Share
0.01
0.01
0.03
0.02
0.03
- -
-0.04
-0.02
-0.01
-0.03
- -
Basic EPS, GAAP
0.01
0.01
-0.02
0.04
0.02
-0.03
0.02
0.03
-0.01
-0.04
- -
Free Cash Flow per Basic Share
- -
0.01
- -
0.01
0.01
- -
- -
- -
- -
- -
- -
Dividend per Share
0.05
0.09
0.11
0.13
0.15
0.15
0.13
0.11
0.09
0.07
0.11
Book Value per Share
0.05
0.08
0.11
0.13
0.15
0.15
0.13
0.09
0.09
0.06
0.1
Tangible Book Value per Share
680
688
800
800
800
800
824
960
1,126
1,354
998
Basic Weighted Avg Shares
172
177
193
224
261
295
213
167
231
168
- -
Sales/Revenue/Turnover
10.33
7.85
13.84
11.06
11.27
2.37
-13.71
-7.6
-4.05
-14.68
- -
Operating Margin (%)
2
2
2
5
6
7
7
5
2
4
- -
Depreciation Expense
9
10
21
19
24
-2
-35
-19
-16
-43
- -
Net Income, GAAP
35.81
31.66
14.4
21.58
17.5
175.24
- -
- -
- -
- -
- -
Effective Tax Rate (%)
5.47
5.4
11.02
8.44
9.03
-0.72
-16.4
-11.16
-7.12
-25.48
- -
Profit Margin (%)
28
60
83
95
99
103
99
97
99
99
116
Working Capital
- -
- -
- -
14
19
16
11
9
1
13
7
LT Debt
37
68
90
105
122
119
123
105
107
97
126
Total Equity
- -
17.5
26.47
18.23
18.59
-1.84
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
18.07
26.82
19.03
19.09
-2.55
- -
- -
- -
- -
- -
Return on Capital (%)
- -
18.07
26.82
19.35
20.78
-1.77
-28.82
-16.35
-15.52
-41.91
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
5
5
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
9
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
960
960
1,140
Market Capitalization
192
92
47

Working Capital

CNY

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
- -
165
217
Cash, Cash Equivalents & STI
- -
76
72
Accounts Receivable, Net
- -
18
41
Inventories
- -
61
76
Total Current Liabilities
- -
67
101
Payables & Accruals
- -
- -
- -
ST Debt
- -
5
5
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-4.25%
-9.74%
Free Cash Flow
- -
82.81%
816.47%
Net Income, GAAP
- -
305.28%
159.85%
Sales/Revenue/Turnover
- -
-5.07%
-27.41%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
167
2024
- -
- -
231
2025
- -
- -
168

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.02
2024
- -
- -
-0.01
2025
- -
- -
-0.03

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Business
China Oral Industry Group Holdings Limited China Oral Industry Group Holdings Limited (8406.HK), an investment holding company incorporated in the Cayman Islands and headquartered in Zhongshan, Guangdong Province, People's Republic of China, principally manufactures and sells inflatable amusement products and related accessories; provides dental clinic services including general dentistry, orthodontics and implantology; sells medical equipment, dental-related products, yarn and polyester; and engages in subcontracting works such as sewing, printing and packaging. The company offers inflatable playgrounds with air blowers, jumping beds, entertainment tents, inflatable ball pools, mini inflatable playgrounds, inflatable tents and other recreational products under the Happyhop, Happyhop Pro and Action Air brands, alongside PVC coatings, PVC laminated oxford and plastic products. Founded in 2003, it operates through three main segments--Inflatable Products Business, Dental Clinic Business, and Yarn and Polyester Business--primarily in the People's Republic of China with sales extending to Europe, Australia, Oceania, North America, rest of Asia, Central and South America, and Africa, targeting consumer discretionary markets in leisure and healthcare. In recent developments, the group completed the acquisition of the entire equity interest in HongKong Taixing Holding Co., Limited and its subsidiaries in January 2024 to enter the yarn and polyester trading business, which contributed 14.6% of total revenue in 2024; acquired Hongkong Eko Holding Co., Limited and subsidiaries in January 2023 to expand dental operations; issued 228 million new shares in January 2025 raising net proceeds of approximately HK$31.72 million for technology research, market expansion and industry chain integration; plans to add three dental medical institutions via new setups and mergers; intends to acquire at least 51% in Guangdong-Hong Kong-Macao Greater Bay Area Health Care Management for healthcare diversification; invests in Beijing Sanyouli's dental pulp cell biotechnology project; and empowers Shenzhen Herui Health International Management Co., Ltd. with Class II medical qualifications while developing an AI lifecycle management system for periodontitis and dental pulp cell treatments.